quinazolines has been researched along with ARPKD in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, K; Nakanuma, Y; Sato, Y | 1 |
| Avner, ED; Frost, P; Harris, PC; Qian, Q; Sweeney, WE; Torres, VE; Wang, X | 1 |
2 other study(ies) available for quinazolines and ARPKD
| Article | Year |
|---|---|
Tissue culture correlational study of genetic cholangiopathy of autosomal recessive polycystic kidney disease.
Topics: Animals; Basement Membrane; Bile Ducts; Blotting, Western; Cell Culture Techniques; Cell Proliferation; Collagen Type IV; Epithelial Cells; Fibrinolysin; Gefitinib; Humans; Matrix Metalloproteinases; Phenotype; Polycystic Kidney, Autosomal Recessive; Quinazolines; Rats; Tissue Culture Techniques; Transforming Growth Factor beta1 | 2013 |
Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats.
Topics: Aminoquinolines; Aniline Compounds; Animals; Cyclic AMP; Disease Models, Animal; ErbB Receptors; Female; Injections, Intraperitoneal; Intubation, Gastrointestinal; Kidney; Male; Organic Chemicals; Polycystic Kidney, Autosomal Recessive; Quinazolines; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Vasopressin; Severity of Illness Index | 2004 |